are glp-1 receptor agonists approved for type 1 diabetes fda individualized treatment of 2 mellitus Evolution of GLP‐1 Receptor Agonists

Dapagliflozin is a weak substrate of the P-glycoprotein (P-gp) active transporter, and dapagliflozin 3-O-glucuronide is a substrate for the OAT3 active transporter

Aging is one of the worst skin problems, but no one can stop the process

Only advanced users with extensive experience managing insulin should even consider this

Some users report mild bloating or temporary fluid retention, particularly with formulations containing sodium salts, but this is not true fat gain

It is commonly used as a solvent for reconstituting lyophilized compounds and preparing multi-dose experimental solutions in controlled research environments